biopharmaceutical

U.S. Food and Drug Administration (FDA) provides feedback necessary to proceed into a phase 2 proof of concept (PoC)/dose ranging study of…

Absci to present in-silico drug discovery technology at NVIDIA GTC Breakthrough ML achievements highlight the viability of the computational lead…

Avacta Group plc (AIM: AVCT), a clinical stage biopharmaceutical company developing innovative cancer therapies and powerful diagnostics based on its…

NexImmune, Inc. and Zephyr AI (Zephyr) announced a strategic partnership focusing on the discovery and validation of novel targets for new…

Biognosys’ TrueSignature proteomics panels serve as pharmacodynamic readout for protein degradation in Kymera’s discovery and clinical trial…

Spesana announced the appointment of John Verniero as Chief Business Officer, Court Veach as Vice President of Sales and Allen Rasoul as Vice…

Business combination projected to deliver $350 million in pro forma 2022 revenue $200 million private placement from leading growth and life…

ReviR Therapeutics, a South San Francisco based biopharmaceutical company, completed a Pre-A financing round with ~$20M. The funds will be used to…

Gothenburg, Sweden – Captario, a Gothenburg-based life sciences decision analytics SaaS platform & services company, has been chosen by Alnylam…

Global professional services firm ZS has been selected by leading biopharmaceutical company Bristol Myers Squibb (BMS) to support its worldwide…